atomoxetine hydrochloride has been researched along with Substance Withdrawal Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, L; Allen, AJ; Escobar, R; Goto, T; Tanaka, Y; Trzepacz, PT; Upadhyaya, HP; Williams, D | 1 |
| Jepson, C; Lerman, C; Lynch, K; Patterson, F; Ray, R; Rukstalis, M; Strasser, A | 1 |
| Geffken, GR; Goldstein, RB; Goodman, WK; Lehmkuhl, H; Murphy, TK; Storch, EA | 1 |
| Davis, JA; Gould, TJ | 1 |
1 trial(s) available for atomoxetine hydrochloride and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Double-Blind Method; Executive Function; Female; Humans; Male; Propylamines; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2014 |
3 other study(ies) available for atomoxetine hydrochloride and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Cognition; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Propylamines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2009 |
Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2009 |
Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Freezing Reaction, Cataleptic; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Propylamines; Substance Withdrawal Syndrome | 2007 |